Cytoreductive surgery and HIPEC (hyperthermic intraperitoneal chemotherapy) in combined treatment of ovarian cancer: time for the beginning of personalized therapy?
, , , , , e
28 set 2019
INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 28 set 2019
Pagine: 154 - 159
Ricevuto: 08 gen 2019
Accettato: 27 mar 2019
DOI: https://doi.org/10.2478/cipms-2019-0028
Parole chiave
© 2019 Roman Yarema et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Yarema, Roman
Danylo Halytsky Lviv National Medical University, Department of Oncology and Medical RadiologyLviv, Ukraine
Volodko, Nataliya
Danylo Halytsky Lviv National Medical University, Department of Oncology and Medical RadiologyLviv, Ukraine
Fetsych, Taras
Danylo Halytsky Lviv National Medical University, Department of Oncology and Medical RadiologyLviv, Ukraine
Оhorchak, Myron
Lviv State Oncological Regional Treatment and Diagnostic CenterLviv, Ukraine
Petronchak, Orest
Lviv State Oncological Regional Treatment and Diagnostic CenterLviv, Ukraine
Mylyan, Yuriy
Lviv State Oncological Regional Treatment and Diagnostic CenterLviv, Ukraine
Makukh, Halyna
SI “Institute of Hereditary Pathology Ukrainian National Academy of Medical Sciences”Lviv, Ukraine